Allergan Launches New Periorbital Treatment Protocol

04 Apr 2014

Today Allergan launches its new treatment protocol for periorbital revitalisation. This new protocol, developed in consultation with twelve European leading medical aesthetics practitioners, incorporates a combination approach of both Botox and the Vycross collection of dermal filler treatments.

Today Allergan launches its new treatment protocol for periorbital revitalisation. This new protocol, developed in consultation with twelve European leading medical aesthetics practitioners, incorporates a combination approach of both Botox and the Vycross collection of dermal filler treatments.

This latest guidance describes a holistic, individualised and stepwise approach for treating this challenging facial region. The new treatment protocol will be launched to over 15,000 medical practitioners across Europe as part of a $6 million training programme, which will be led by leading global surgeon, Dr Mauricio De Maio.

Dr Kambiz Golchin, consultant ENT and facial plastic surgeon, said, “From my own clinical practice, I see high numbers of patients who want to refresh their eye area and address key ageing concerns like eye bags and crow’s feet lines, but who are concerned about maintaining a natural looking result and keeping their expressions.

 “This is where Allergan’s new periorbital treatment protocol can play a role in guiding physicians through the treatment options now available for this complex area, in order to deliver results which reflect patients’ unique characteristics, ethnicity and personal treatment goals. Expert training is key to ensuring these treatments are used correctly to deliver optimal results for patients.”

Comments

Log-in to post a comment